BayBio Announces the 10th Annual Pantheon Award Winners
SOUTH SAN FRANCISCO, CA – Oct. 3, 2013 – A prolific investor, responsible for dozens of successful life science companies, and a professor, whose seminal work helped launch the biotechnology industry as we know it, are among the luminaries being celebrated at this year’s 10th annual BayBio Pantheon DiNA Awards ceremony.
Sam Colella, a partner at Silicon Valley based Versant Ventures, and Dr. Stanley N. Cohen, a researcher in Stanford University’s department of genetics and medicine, and well known as an inventor on the Cohen/Boyer gene cloning patent – responsible for launching industry giants like Genentech and Amgen – will receive Lifetime Achievement Awards for their contributions to making a transformative difference within the life science industry.
Other leading executives, researchers and dedicated individuals will receive DiNA Awards for the following categories (listed alphabetically by award title):
- Biotechnology Educator Award – Tom McFadden, KIPP Bridge Middle School in Oakland, CA
- Biotechnology Philanthropist Award – Scott Johnson, Myelin Repair Foundation
- Global Reach Award – Boehringer Ingelheim Fremont, Inc (BIFI)
- Outstanding Company Award – Portola Pharmaceuticals
- Outstanding Partnering Award – Ardelyx
- Outstanding Public Support Award – Rep. Jackie Speier (D – Hillsborough)
- Outstanding Product Award (Therapeutic) – COMETRIQ (cabozantinib) by Exelixis
- Rising Star Award – Jennifer Doudna, UC Berkeley
- Scientific Achievement Award – Deepak Srivastava, Gladstone Institutes
“BayBio’s Pantheon Ceremony celebrates the advancements and unparalleled innovative excellence of the Bay Area’s life science industry,” said BayBio President and CEO Gail Maderis. “We applaud the people and companies who have dedicated their work to improving patients’ health.
BayBio brings together the collective strength and experience of the world’s most innovative and productive life science cluster, helping companies grow, connect and advocate to solve some of humanity’s most pressing challenges. BayBio provides comprehensive support and solutions tailored to the unique needs of nearly 1000 Bay Area life science companies and institutions, delivering tangible value through group purchasing savings, capital access, government affairs & advocacy, networking and best-practice sharing. BayBio also supports the future of bioscience innovation through the BayBio Institute’s work in science education, career development and entrepreneurship.